Mr. Rosengart is currently the President and CEO of HK & Associates, an investment and consulting firm which provides advice to small and medium-sized life sciences companies and life-science investment firms. Previously, he founded several privately held companies, including LigoChem, Inc., a DNA\RNA and macromolecule bioseparations company founded in 1995; SunPharm Corporation, a polyamine based anti-cancer drug development-stage company founded in 1991 and Syncom Pharmaceuticals, Inc., a contract sales force organization founded in 1991. Between 1981 and 1990, Mr. Rosengart spent almost ten years as a banker and investment banker with the Chase Manhattan Bank, NA, focusing on the pharmaceutical and chemical industries. Prior to joining Chase Manhattan Bank, he spent over ten years with several pharmaceutical and chemical multinational companies in various managerial positions. Mr. Rosengart holds a B.S. in Chemical Engineering and an M.B.A. from Rutgers University.

Wendell H. Adair, Jr. is a member of M&A Development Company LLC, a real estate development firm. He is a senior lawyer with 35 years of experience specializing in restructuring and corporate finance. Until April 2006, he held Senior Partner positions at leading U.S. law firms, including Stroock & Stroock & Lavan LLP from September 1999 to April 2006 and McDermott, Will & Emery from September 1989 to September 1999. He is currently a member of the board of directors of Atari, Inc., currently serves and has previously served on the boards of private companies and has advised corporate boards with respect to governance, fiduciary duty and financing matters.

Since founding Dyadic in 1979, Mr. Emalfarb has successfully led and managed the evolution of Dyadic -- from its origins as a pioneer and leader in providing ingredients used in stone-washing of blue jeans -- to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of the C1 Expression System. Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to Dyadic’s proprietary C1 microorganism, and has been the architect behind its formation of several strategic R&D, manufacturing and marketing relationships with U.S. and international partners. Mr. Emalfarb earned a B.A. degree from the University of Iowa.

Mr. Warner has served as a director of Dyadic since August 15, 2004. He currently serves as Managing Partner of Bioform LLC, a newly established Florida-based venture capital fund focused on investments in biotechnology companies. Mr. Warner has over 25 years of venture capital experience. In 1981, Mr. Warner founded Merrill Lynch Venture Capital Inc., a wholly owned subsidiary of Merrill Lynch & Co. Inc. in New York and served as its President and Chief Executive Officer from 1981 to 1990. Under his leadership, Merrill Lynch Venture Capital managed over $250 million and made over 50 venture capital investments. In 1999, Warner co-founded and became Chairman/CEO, of Crossbow Ventures Inc., a private equity fund that invests in early and expansion stage technology companies primarily located in Florida and the Southeast, with over 20 venture capital investments in Florida. Mr. Warner earned a B.S. degree from the Massachusetts Institute of Technology and an MBA from the Wharton School of Business, University of Pennsylvania.

Mr. Moor joined the company in February 2005 and has previously served as a chief financial officer of several public companies, and has over 25 years experience in real estate and hotel operations, asset management, debt restructurings, recapitalizations and developing strategic turnaround plans. Prior to Dyadic, Mr. Moor served as Chief Financial Officer of a number of companies, including Boca Resorts, Inc., ANC, the parent company of Alamo and National rental car companies, Gerald Stevens, Inc., a floral products marketer and retailer, US Diagnostic, Inc., an operator of outpatient medical diagnostic imaging and related facilities, and a number of other privately and publicly held financial institutions and real estate operating companies. Mr. Moor received his undergraduate degree in Accounting from University of Montevallo and is a Certified Public Accountant.